10x Genomics, Inc. Class A Common Stock (TXG) Financials

Key financial figures for 10x Genomics, Inc. Class A Common Stock (Q1 2026).

Revenue

$151M

Net Income

-$13M

EPS

$-0.10

Total Assets

$1.0B

Operating Cash Flow

$26M

Full income statement, balance sheet, and cash flow for 10x Genomics, Inc. Class A Common Stock on SentiSense.